23 July 2021 | News
Enabling manufacturers to establish sound pharma supply chains for APIs, dose forms, excipients, intermediates and more
Photo Credit: Clarivate
Clarivate Plc has launched Cortellis Supply Chain Network™, a part of the Cortellis suite of life science intelligence solutions. The solution supports generics companies, Active Pharmaceutical Ingredients (API) manufacturers, fine chemical manufacturers, excipient manufacturers, raw materials suppliers, and biopharma in their pursuit to maintain a steady supply chain -- ultimately making therapies easily accessible to all patients.
The Cortellis Supply Chain Network can connect more than 70K+ companies – buyers and sellers – with more data added by the expert research team and directly by users every day.
Cortellis Supply Chain Network provides buyers and sellers with a secure marketplace that allows them to identify potential partners, connect with the right point of contact, and efficiently manage all steps, from quotation to finalizing the deal. With an increased demand for more accessible therapies, the network will enable industry players to build robust supply chains and identify alternate sources during unprecedented times.
Identifying alternate API sources and other critical ingredients to prevent manufacturing delays caused by unexpected events, can help build a resilient supply chain. Cortellis Supply Chain Network provides access to continuously updated manufacturing data, saving users time in confidently assessing potential partners. High-quality product data is paired with primary research on API manufacturers to verify their pipeline and manufacturing capabilities. Users can monitor and manage supply risk with insights on the latest inspections, warning letters, GMP Certificates, supply issues and more. In addition, it provides users with personalized updates, documentation, and alerts to support overall supply transparency in the industry.
The Cortellis Supply Chain Network is powered by the Clarivate Research Intelligence Cloud™ -- allowing more comprehensive research and analysis during market assessment activities.
Keith Collier SVP Product - Science, Clarivate, said: "We are committed to supporting across the entire drug, device and medical technology lifecycles to drive clinical and commercial success. Cortellis Supply Chain Network aims to open communication channels between manufacturers, provide insights on supply capabilities or vulnerabilities and facilitate deal-making."